Tag: David M. Lee

Janssen to acquire skin disease drug candidate bermekimab from XBiotech

pharmanewsdaily- December 8, 2019

Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to acquire all rights to bermekimab, an investigational ... Read More

Janssen bags Stelara FDA approval for ulcerative colitis treatment

pharmanewsdaily- October 22, 2019

Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged approval from the US Food and Drug ... Read More